Page 3 - Maxcyte Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maxcyte company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maxcyte Company Profile Today - Breaking & Trending Today

MaxCyte (LON:MXCT) Trading 9.1% Higher

MaxCyte, Inc. (LON:MXCT – Get Free Report) shares shot up 9.1% during trading on Monday . The company traded as high as GBX 390 ($5.02) and last traded at GBX 382 ($4.91). 90,546 shares changed hands during trading, an increase of 226% from the average session volume of 27,791 shares. The stock had previously closed […] ....

United States , Doug Doerfler , Maxcyte Company Profile , Maxcyte Inc , Get Free Report , Numis Securities , Cyte Stock Down , Maxcyte Daily ,

MaxCyte (NASDAQ:MXCT) Trading 7.1% Higher

MaxCyte, Inc. (NASDAQ:MXCT – Free Report) shares were up 7.1% on Monday . The stock traded as high as $4.96 and last traded at $4.96. Approximately 134,093 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 514,905 shares. The stock had previously closed at $4.63. Wall Street Analyst […] ....

United States , John Joseph Johnston , Thomasm Ross , Maxcyte Company Profile , Cubist Systematic Strategies , Maxcyte Inc , Charles Schwab Investment Management Inc , Gagnon Securities , Securities Exchange Commission , Blair William Co , Free Report , Exchange Commission , Director John Joseph Johnston , Systematic Strategies , Charles Schwab Investment Management , Schwab Investment Management , Maxcyte Daily ,

MaxCyte, Inc. (NASDAQ:MXCT) CEO Douglas Doerfler Sells 14,968 Shares of Stock

MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) CEO Douglas Doerfler sold 14,968 shares of the company’s stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $5.03, for a total transaction of $75,289.04. Following the completion of the transaction, the chief executive officer now owns 333,197 shares […] ....

Douglas Doerfler , Moors Cabot Inc , Tower Research Capital , Cubist Systematic Strategies , Maxcyte Company Profile , Maxcyte Inc , Pricet Rowe Associates Inc , Get Rating , Cyte Trading Down , Research Capital , Systematic Strategies , Pricet Rowe Associates , Maxcyte Daily ,

Insider Selling: MaxCyte, Inc. (NASDAQ:MXCT) CEO Sells 14,968 Shares of Stock

MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) CEO Douglas Doerfler sold 14,968 shares of MaxCyte stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $5.03, for a total transaction of $75,289.04. Following the completion of the transaction, the chief executive officer now directly owns 333,197 shares […] ....

Douglas Doerfler , Securities Exchange Commission , Lazard Asset Management , Maxcyte Company Profile , Granahan Investment Management , Grandeur Peak Global Advisors , Maxcyte Inc , Goldman Sachs Group Inc , Get Rating , Exchange Commission , Asset Management , Peak Global Advisors , Investment Management , Goldman Sachs Group , Sachs Group , Maxcyte Daily , Nasdaq Mxct , Insider Trading , Nsider Trades ,

MaxCyte (LON:MXCT) Trading Up 3%

MaxCyte, Inc. (LON:MXCT – Get Rating)’s share price was up 3% on Monday . The stock traded as high as GBX 340 ($4.23) and last traded at GBX 340 ($4.23). Approximately 56,453 shares changed hands during mid-day trading, an increase of 86% from the average daily volume of 30,378 shares. The stock had previously closed […] ....

Doug Doerfler , Maxcyte Inc , Maxcyte Company Profile , Get Rating , Numis Securities , Maxcyte Daily , Lon Mxct ,